SS Innovations International, Inc. (SSII): who owns it and who trades it
As of Oct 30, 2026, SSII insiders reported 1 open-market sale worth $100K and 3 purchases worth $5.2M in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Srivastava Sudhir (CEO), with $100K.
Latest filing Oct 30, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Insider trades
In the last 12 months, SSII insiders reported $5.2M of open-market purchases and $100K of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 4, 2026 | Srivastava Sudhir | CEO | Sale | 33,333 | $3.00 | $100K | Form 4 |
| Mar 6, 2026 | Frederic H Moll | Director | Purchase | 501,253 | $3.99 | $2M | Form 4 |
| Mar 6, 2026 | Timothy P. Adams | Director | Purchase | 300,000 | $3.99 | $1.2M | Form 4 |
| Mar 6, 2026 | Srivastava Sudhir | CEO | Purchase | 498,753 | $4.01 | $2M | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Srivastava Sudhir | Chairman and CEO, Director, 10% owner | $2M | $100K | Sep 4, 2026 |
| Frederic H Moll | Director, 10% owner | $2M | – | Mar 6, 2026 |
| Timothy P. Adams | Director | $1.2M | – | Mar 6, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
SSII short interest
Low short interest. Less than 0.1% of SSII shares are sold short. Over the last 12 reports the number of shares short went up 11%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 64,284 SSII shares were sold short, 0.0% of the shares outstanding, down 7.6% from the report before. At the average daily volume of 56,614 shares, buying them all back would take about 1.1 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 64,284 | 0.03% | -8% | 56,614 | 1.1 |
| Oct 15, 2026 | 69,591 | 0.03% | +3% | 58,827 | 1.2 |
| Sep 30, 2026 | 67,764 | 0.03% | +14% | 79,569 | 1.0 |
| Sep 15, 2026 | 59,661 | 0.03% | -18% | 60,995 | 1.0 |
| Aug 31, 2026 | 73,141 | 0.04% | +8% | 38,216 | 1.9 |
| Aug 14, 2026 | 67,925 | 0.03% | -14% | 41,404 | 1.6 |
| Jul 31, 2026 | 79,040 | 0.04% | -40% | 89,917 | 1.0 |
| Jul 15, 2026 | 131,067 | 0.07% | +179% | 65,049 | 2.0 |
| Jun 30, 2026 | 46,918 | 0.02% | -12% | 60,040 | 1.0 |
| Jun 15, 2026 | 53,133 | 0.03% | +3% | 78,373 | 1.0 |
| May 29, 2026 | 51,578 | 0.03% | -11% | 51,998 | 1.0 |
| May 15, 2026 | 58,021 | 0.03% | +18% | 48,664 | 1.2 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
SS Innovations International company events
SS Innovations International filed 29 reports on Form 8-K in the last 12 months, 4 of them about an important change (leadership). The latest was on Oct 26, 2026.
- Oct 26, 2026AnnouncementSSi issued a press release announcing that the Company’s SSi Mantra surgical robotic system and SSi MantrAsana tele-surgeon console were showcased in successful telesurgeries performed in October 2026 during the European Association for Cardio-Thoracic Surgery Annual Meeting in Barcelona, Spain and… Filing
- Oct 13, 2026AnnouncementSSi issued a press release announcing that, on October 5, 2026, the Company submitted its response to a request for additional information letter received from the United States Food and Drug Administration with respect to its 510(k) application for SSi’s SSi Mantra surgical robotic system. Filing
- Oct 13, 2026AgreementSSi entered into a Securities Purchase Agreement with an institutional investor, and consummated the transactions contemplated thereby. Filing
- Oct 5, 2026AnnouncementShared information with investors. Filing
- Sep 10, 2026AnnouncementSSi issued a press release which provided an update on the Company’s continuing progress and milestones. Filing
- Aug 26, 2026LeadershipSarah Romano is no longer serving as Chief Financial Officer of the Company. Filing
- Aug 13, 2026ResultsReleased financial results. Filing
- Jul 17, 2026AnnouncementSSi issued a press release announcing that the Company’s advanced SSi Mantra surgical robotic system will be showcased at the 2026 Society of Robotic Surgery Annual Meeting in Hollywood, Florida on July 23 - 26, 2026. Filing
- Jul 14, 2026LeadershipReported a change among its top officers or directors, or their pay. Filing
- Jul 7, 2026AnnouncementSSi issued a press release announcing that the Company’s subsidiary, the SS International Centre for Robotics Surgery, has graduated its first class in a specialized training course designed to provide surgeons and other healthcare professionals with classroom instruction and hands-on learning in… Filing
- Jun 30, 2026AnnouncementSSi issued a press release announcing the Company was named the winner of the Outstanding Company category at the 2026 Surgical Robotics Industry Awards. Filing
- Jun 18, 2026AgreementThe Company entered into an ATM Sales Agreement with Virtu Americas LLC, to sell shares of its common stock, par value $0.0001 per share, for an aggregate offering price of up to $50 million from time to time, through an “at the market offering” program under which Virtu will act as an exclusive… Filing
- Jun 15, 2026AnnouncementShared information with investors. Filing
- Jun 4, 2026AnnouncementSSi issued a press release announcing that the world’s longest-distance robotic telesurgery was successfully performed on May 26, 2026, utilizing the Company’s SSi Mantra surgical robotic system, from Georgetown, Guayana to a patient in Indore, India, at a communication line distance of more than… Filing
- May 26, 2026LeadershipMilan Rao informed the Company that he would step down as Global Chief Operating Officer and Chief Financial Officer, effective May 25, 2026. Filing
- May 13, 2026ResultsReleased financial results. Filing
- May 7, 2026AnnouncementSSi issued a press release announcing the successful completion of a long-distance cross-border telesurgery utilizing the SSi Mantra surgical robotic system and the SSi MantrAsana tele-surgeon console and spanning more than 6,000 miles from the surgeon located at the Royal Australian College of… Filing
- May 5, 2026AnnouncementSSi issued a press release announcing that more than 10,500 cumulative surgeries have been successfully performed with the Company’s SSi Mantra surgical robotic system. Filing
- Apr 23, 2026AnnouncementShared information with investors. Filing
- Apr 7, 2026AnnouncementSSi issued a press release announcing it is hosting the Global Multi-Specialty Robotic Surgery Conference (SMRSC 2026), being held in New Delhi, India, from April 9 to 11, 2026. Filing
- Mar 30, 2026AnnouncementThe Company issued a press release announcing that it had received regulatory approval for the SSi Mantra surgical robotic system for multiple indications in Colombia, Oman, Sri Lanka and Kenya. Filing
- Mar 18, 2026AnnouncementThe Company issued a press release announcing that its SSi Mantra surgical robotic system has been approved for telesurgeries in Indonesia and the Philippines and updating the number of telesurgeries performed utilizing the SSi Mantra. Filing
- Mar 10, 2026ResultsReleased financial results. Filing
- Mar 9, 2026SharesSold new shares outside a public offering. Filing
- Jan 13, 2026ResultsReleased financial results. Filing
- Jan 8, 2026LeadershipReported a change among its top officers or directors, or their pay. Filing
- Jan 6, 2026AnnouncementThe Company issued a press release announcing that SSi had completed the development of five new 5-millimeter surgical instruments for clinical use across multiple specialties, including pediatric, cardiac, and head and neck surgery, among other procedures involving smaller anatomical structures. Filing
- Dec 16, 2025AnnouncementShared information with investors. Filing
- Dec 8, 2025AnnouncementThe Company issued a press release announcing that the Company submitted a 510(k) premarket notification to the United States Food and Drug Administration on December 5, 2025, for its SSi Mantra surgical robotic system for multiple specialty procedure types, including: general, urological… Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
SS Innovations International financials
Questions about SS Innovations International, Inc. (SSII) stock
Are SSII insiders buying or selling?
In the last 12 months, SSII insiders reported 3 open-market purchases worth $5.2M and 1 sale worth $100K. The latest trade was on Sep 4, 2026. See every trade.
What is the short interest in SSII?
As of Oct 30, 2026, 64,284 SSII shares were sold short, 0.0% of the shares outstanding, down 7.6% from the report before. At the average daily volume of 56,614 shares, buying them all back would take about 1.1 trading days (days to cover). See the history.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.